Regulation

  • Read more: Suicide Prevention and Patient Safety

    Suicide Prevention and Patient Safety

    By John Tingle Suicide prevention needs to be taken more seriously globally by governments, health systems as an urgent public health concern. WHO (World Health Organisation) states that close to 800,000 people die due to suicide every year, which translates to one person dying every 40 seconds. For each adult who died by suicide there…

    Black silhouette of girl with a pony tail looking down in a dark tunnel
  • Read more: Patient Safety and Communication Breakdown

    Patient Safety and Communication Breakdown

    By John Tingle Good communication is an essential prerequisite for good and safe patient care. To effectively communicate is an everyday life skill and it’s one of the most basic that we all must master in some way. From a patient safety context, poor health carer communication practices are a worldwide problem which continues to…

    Digital text reading "No Signal"
  • Read more: Patient Safety Failings in Independent Acute Hospitals in England

    Patient Safety Failings in Independent Acute Hospitals in England

    By John Tingle One thing that strikes the UK visitor to the USA is the vast array of  large public and private hospitals that exist with many having trauma and emergency rooms. Private hospitals don’t exist on this scale in the UK. Our major hospitals are public, state run NHS (National Health Service) hospitals. Independent,…

  • Read more: Simulated Side Effects: FDA Uses Novel Computer Model to Guide Kratom Policy

    Simulated Side Effects: FDA Uses Novel Computer Model to Guide Kratom Policy

    By Mason Marks FDA Commissioner Scott Gottlieb issued a statement on Tuesday about the controversial plant Mitragyna speciosa, which is also known as kratom. According to Gottlieb, kratom poses deadly health risks. His conclusion is partly based on a computer model that was announced in his recent statement. The use of simulations to inform drug…

  • Read more: The Opioid Crisis Requires Evidence-Based Solutions, Part II: How the President’s Commission on Combating Drug Addiction Ignored Promising Medical Treatments

    The Opioid Crisis Requires Evidence-Based Solutions, Part II: How the President’s Commission on Combating Drug Addiction Ignored Promising Medical Treatments

    By Mason Marks Last year more than 64,000 Americans died of drug overdose, which is “now the leading cause of death” in people under 50. Opioids kill an estimated 91 Americans each day and are responsible for most drug-related deaths in the US. This public health crisis requires solutions that are supported by science and…

  • Read more: The Opioid Crisis Requires Evidence-Based Solutions, Part I: How the President’s Commission on Combating Drug Addiction Misinterpreted Scientific Studies

    The Opioid Crisis Requires Evidence-Based Solutions, Part I: How the President’s Commission on Combating Drug Addiction Misinterpreted Scientific Studies

    By Mason Marks The opioid crisis kills at least 91 Americans each day and has far-reaching social and economic consequences for us all. As lawmakers explore solutions to the problem, they should ensure that new regulations are based on scientific evidence and reason rather than emotion or political ideology. Though emotions should motivate the creation…

  • Read more: Patenting Bioprinting Technologies in the US and Europe – The Fifth Element in the Third Dimension

    Patenting Bioprinting Technologies in the US and Europe – The Fifth Element in the Third Dimension

    By Timo Minssen I am happy to announce the publication of our new working paper on  “Patenting Bioprinting Technologies in the US and Europe – The 5th element in the 3rd dimension.” The paper, which has  been co-authored by Marc Mimler, starts out by describing the state of the art and by examining what sorts of bioprinting inventions…

  • Read more: Innovation and Intellectual Property Policies in European Research Infrastructure Consortia

    Innovation and Intellectual Property Policies in European Research Infrastructure Consortia

    By Timo Minssen I am happy to announce the publication of our collaborative paper with Helen Yu and Jakob Wested on “Innovation and intellectual property policies in European Research Infrastructure Consortia (part I)” in the Journal of Intellectual Property Law and Practice (Oxford University Press). Taking the European Spallation Source ERIC as an example, our paper investigates ERIC Regulations…